23 Daily — According to techcrunch.com, health tracking brand Oura announced on November 10, 2026, that it is acquiring AI-native primary care startup Counsel Health for $625 million. This acquisition follows just weeks after Oura indefinitely postponed its planned IPO, which was expected to be up to .2 billion, citing uncertainty in the IPO market.
Counsel Health: AI-powered Primary Care Platform with Physician Access
Counsel Health operates an AI-driven healthcare platform that combines a chat-based medical experience with access to licensed physicians. The service was integrated into the Oura app in June 2026, allowing users to obtain personalized medical advice through Counsel’s AI and consult with physicians when necessary, all within the Oura app. Post-acquisition, the companies intend to expand collaboration across preventive care, acute care, and specialty and chronic disease management.
Oura's Strategic Move Amid Market Competition
Oura has dominated the smart ring market for years but faces increasing competition from emerging rivals like RingConn and Ultrahuman. This acquisition aims to help Oura broaden its service portfolio and deepen user engagement by providing access to medical care. Oura CEO Tom Hale stated that while Oura helps members understand their physiology, integrating Counsel’s capabilities enables users to take action on a variety of health needs, ranging from quick questions and prescriptions to lab results, chronic care, and referrals.
Post-Acquisition Plans and Company Performance
Counsel Health had raised approximately $36 million, including a 5 million Series A led by Andreessen Horowitz (a16z) and GV about a year ago. After closing, Counsel will continue serving current and new enterprise partners and aims to scale its AI-native care model beyond Oura's membership base. Counsel CEO Muthu Alagappan will join Oura as chief clinical AI officer, leading a team of 70 employees. Oura highlighted the mutual emphasis on trust, safety, and physician oversight in AI medical decisions. Financially, Oura reported $533 million in revenue for the quarter ending September 30, a 153% year-over-year increase, and approximately
Editor's take: New Opportunities and Validation Paths for Entrepreneurs
This $625 million acquisition underscores the significant potential of combining AI with healthcare, particularly in primary care. For entrepreneurs, it highlights how AI-native medical platforms can extend and differentiate by integrating with hardware health tracking devices, offering deeper and broader services. Startup teams can validate this model by developing integrated health management tools coupled with AI-assisted medical advice, targeting a broad user base and enterprise partners. Validation methods include integrating with vertical hardware or health data sources, analyzing user behavior and clinical quality feedback, ensuring physician involvement in clinical decisions, and continuously improving AI recommendation accuracy and safety, gradually expanding service scope and partnerships.